CATHERINE J. MACKEY - 01 Jul 2021 Form 4 Insider Report for Trillium Therapeutics Inc.

Role
Director
Signature
/s/ James Parsons, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4
Filing time
02 Jul 2021, 16:35:54 UTC
Previous filing
02 Jul 2021
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRIL Stock Option (Right to Buy) Award $0 +67,000 $0.000000 67,000 01 Jul 2021 Common Shares 67,000 $9.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the options vest on the one year anniversary of the grant date and the remaining options vest in equal quarterly installments over the following two years.